Alterations in protein SUMOylation are observed in a wide range of neurological and neurodegenerative diseases including tauopathies (126–128), and several extranuclear disease-associated proteins including tau have been shown to be directly SUMOylated (125). This evidence concerns the gene MAPT and neurodegenerative disease.